RM Global Bioaccess Fund Management
Open
880 3rd Ave
New York, NY 10022
RM Global BioAccess Fund Management is dedicated to accelerating innovative science to develop new medicines through strategic partnerships with forward-thinking companies. The fund focuses on transformative technologies aimed at addressing significant unmet medical needs in oncology, rare diseases, central nervous system (CNS) disorders, and cardiology.
With a commitment to investing in early-stage companies, the Global BioAccess Fund provides essential capital to support investigational new drug (IND) submissions and clinical trials. Their mission centers around fostering advancements in therapeutics and devices that can ultimately improve patient outcomes in critical health areas.
Generated from the website
Also at this address
See a problem?